- Home
- INMB vs MKTW Comparison
INMB vs MKTW Comparison
Compare INMB & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- MKTW
- Stock Information
- Founded
- INMB 2015
- MKTW 1999
- Country
- INMB United States
- MKTW United States
- Employees
- INMB N/A
- MKTW N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- MKTW Computer Software: Prepackaged Software
- Sector
- INMB Health Care
- MKTW Technology
- Exchange
- INMB Nasdaq
- MKTW Nasdaq
- Market Cap
- INMB 53.4M
- MKTW 48.2M
- IPO Year
- INMB 2019
- MKTW N/A
- Fundamental
- Price
- INMB $1.91
- MKTW $17.06
- Analyst Decision
- INMB Buy
- MKTW Hold
- Analyst Count
- INMB 4
- MKTW 1
- Target Price
- INMB $9.53
- MKTW $20.00
- AVG Volume (30 Days)
- INMB 822.2K
- MKTW 10.9K
- Earning Date
- INMB 10-30-2025
- MKTW 11-06-2025
- Dividend Yield
- INMB N/A
- MKTW 4.64%
- EPS Growth
- INMB N/A
- MKTW 59.71
- EPS
- INMB N/A
- MKTW 2.83
- Revenue
- INMB $50,000.00
- MKTW $358,121,000.00
- Revenue This Year
- INMB $142.83
- MKTW N/A
- Revenue Next Year
- INMB $14,780.90
- MKTW N/A
- P/E Ratio
- INMB N/A
- MKTW $6.09
- Revenue Growth
- INMB N/A
- MKTW N/A
- 52 Week Low
- INMB $1.71
- MKTW $9.08
- 52 Week High
- INMB $11.64
- MKTW $21.74
- Technical
- Relative Strength Index (RSI)
- INMB 38.01
- MKTW 39.53
- Support Level
- INMB $1.71
- MKTW $17.70
- Resistance Level
- INMB $2.12
- MKTW $18.30
- Average True Range (ATR)
- INMB 0.12
- MKTW 0.45
- MACD
- INMB 0.04
- MKTW -0.04
- Stochastic Oscillator
- INMB 45.45
- MKTW 7.14
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.